Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?
Alonso R, Argüeso R, Álvarez-Baños P, Muñiz-Grijalvo O, Diaz-Diaz JL, Mata P. Alonso R, et al. Among authors: alvarez banos p. Curr Atheroscler Rep. 2022 Jun;24(6):427-434. doi: 10.1007/s11883-022-01019-5. Epub 2022 Apr 7. Curr Atheroscler Rep. 2022. PMID: 35386090 Review.
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study.
Pérez de Isla L, Arroyo-Olivares R, Muñiz-Grijalvo O, Diaz-Díaz JL, Zambón D, Fuentes F, Sánchez Muñoz-Torrero JF, Mediavilla JD, González-Estrada A, Miramontes-González JP, de Andrés R, Mauri M, Mosquera D, Cepeda JM, Suárez L, Barba-Romero MÁ, Argüeso R, Álvarez-Baños P, Michán A, Romero-Jiménez MJ, García-Cruces J, Padró T, Alonso R, Mata P. Pérez de Isla L, et al. Among authors: alvarez banos p. J Clin Lipidol. 2019 Nov-Dec;13(6):989-996. doi: 10.1016/j.jacl.2019.10.005. Epub 2019 Oct 11. J Clin Lipidol. 2019. PMID: 31706904 Free article.
Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience.
Alonso R, Muñiz-Grijalvo O, Díaz-Díaz JL, Zambón D, de Andrés R, Arroyo-Olivares R, Fuentes-Jimenez F, Muñoz-Torrero JS, Cepeda J, Aguado R, Alvarez-Baños P, Casañas M, Dieguez M, Mañas MD, Rubio P, Argueso R, Arrieta F, Gonzalez-Bustos P, Perez-Isla L, Mata P; SAFEHEART investigators. Alonso R, et al. Among authors: alvarez banos p. J Clin Lipidol. 2021 Jul-Aug;15(4):584-592. doi: 10.1016/j.jacl.2021.04.011. Epub 2021 May 7. J Clin Lipidol. 2021. PMID: 34052174
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study.
de Isla LP, Vallejo-Vaz AJ, Watts GF, Muñiz-Grijalvo O, Alonso R, Diaz-Diaz JL, Arroyo-Olivares R, Aguado R, Argueso R, Mauri M, Romero MJ, Álvarez-Baños P, Mañas D, Cepeda JM, Gonzalez-Bustos P, Casañas M, Michan A, Muñoz-Torrero JFS, Faedo C, Barba MA, Dieguez M, de Andrés R, Hernandez AM, Gonzalez-Estrada A, Padró T, Fuentes F, Badimon L, Mata P; SAFEHEART Investigators. de Isla LP, et al. Among authors: alvarez banos p. Lancet Diabetes Endocrinol. 2024 Sep;12(9):643-652. doi: 10.1016/S2213-8587(24)00192-X. Epub 2024 Aug 1. Lancet Diabetes Endocrinol. 2024. PMID: 39098315
Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study.
Pérez de Isla L, Díaz-Díaz JL, Romero MJ, Muñiz-Grijalvo O, Mediavilla JD, Argüeso R, de Andrés R, Fuentes F, Sánchez Muñoz-Torrero JF, Rubio P, Álvarez-Baños P, Mañas D, Suárez Gutierrez L, Saltijeral Cerezo A, Mata P; SAFEHEART Investigators. Pérez de Isla L, et al. Among authors: alvarez banos p. Circ Cardiovasc Imaging. 2024 Jan;17(1):e016206. doi: 10.1161/CIRCIMAGING.123.016206. Epub 2024 Jan 11. Circ Cardiovasc Imaging. 2024. PMID: 38205656
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study.
Pérez de Isla L, Díaz-Díaz JL, Romero MJ, Muñiz-Grijalvo O, Mediavilla JD, Argüeso R, Sánchez Muñoz-Torrero JF, Rubio P, Álvarez-Baños P, Ponte P, Mañas D, Suárez Gutierrez L, Cepeda JM, Casañas M, Fuentes F, Guijarro C, Ángel Barba M, Saltijeral Cerezo A, Padró T, Mata P; SAFEHEART Study Group. Pérez de Isla L, et al. Among authors: alvarez banos p. Circulation. 2023 May 9;147(19):1436-1443. doi: 10.1161/CIRCULATIONAHA.122.062557. Epub 2023 Apr 3. Circulation. 2023. PMID: 37009731 Free PMC article.
Association Between Insulin-Like Growth Factor-1 and Social Cognition in Huntington's Disease.
Gil-Polo C, Martinez-Horta SI, Sampedro Santalo F, Martín-Palencia M, Gundín-Menéndez S, Alvarez-Baños P, Maza-Pereg L, Calvo S, Collazo C, Alonso-García E, Riñones-Mena E, Arrabal-Alonso A, Núñez Rodriguez J, Saiz-Rodriguez M, Aguado L, Mariscal N, Muñoz-Siscart I, Piñeiro D, Rivadeneyra J, Diez-Fairen M, Miguel-Pérez I, Cubo E. Gil-Polo C, et al. Among authors: alvarez banos p. Mov Disord Clin Pract. 2022 Dec 10;10(2):279-284. doi: 10.1002/mdc3.13613. eCollection 2023 Feb. Mov Disord Clin Pract. 2022. PMID: 36825059 Free PMC article.
Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study.
Alonso R, Arroyo-Olivares R, Muñiz-Grijalvo O, Díaz-Díaz JL, Muñoz-Torrero JS, Romero MJ, de Andrés R, Zambón D, Mañas MD, Fuentes-Jiménez F, Aguado R, Alvarez-Baños P, Arrieta F, Gonzalez-Bustos P, Cepeda J, Martin-Ordiales M, Mosquera D, Michan A, de Isla LP, Argueso R, Mata P. Alonso R, et al. Among authors: alvarez banos p. Eur J Prev Cardiol. 2023 Mar 1;30(4):320-328. doi: 10.1093/eurjpc/zwac277. Eur J Prev Cardiol. 2023. PMID: 36416136